Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

BUY
$306.88 - $380.0 $18,412 - $22,800
60 Added 10.85%
613 $231,000
Q3 2023

Nov 14, 2023

BUY
$315.92 - $397.36 $11,057 - $13,907
35 Added 6.76%
553 $175,000
Q1 2023

May 11, 2023

BUY
$323.56 - $373.36 $12,295 - $14,187
38 Added 7.92%
518 $193,000
Q4 2022

Feb 10, 2023

BUY
$248.67 - $334.17 $59,929 - $80,534
241 Added 100.84%
480 $158,000
Q3 2022

Nov 10, 2022

SELL
$263.81 - $337.27 $11,871 - $15,177
-45 Reduced 15.85%
239 $63,000
Q2 2022

Aug 09, 2022

BUY
$301.4 - $428.42 $29,537 - $41,985
98 Added 52.69%
284 $89,000
Q1 2022

May 06, 2022

BUY
$379.46 - $424.54 $3,794 - $4,245
10 Added 5.68%
186 $77,000
Q3 2021

Nov 12, 2021

BUY
$396.76 - $455.92 $5,554 - $6,382
14 Added 8.64%
176 $73,000
Q2 2021

Aug 09, 2021

SELL
$372.36 - $412.07 $6,702 - $7,417
-18 Reduced 10.0%
162 $64,000
Q1 2021

May 12, 2021

BUY
$357.26 - $392.57 $8,574 - $9,421
24 Added 15.38%
180 $69,000
Q4 2020

Feb 16, 2021

SELL
$319.05 - $363.32 $9,890 - $11,262
-31 Reduced 16.58%
156 $57,000
Q3 2020

Nov 13, 2020

BUY
$280.08 - $347.78 $24,647 - $30,604
88 Added 88.89%
187 $63,000
Q2 2020

Aug 13, 2020

SELL
$270.93 - $320.3 $124,356 - $147,017
-459 Reduced 82.26%
99 $28,000
Q1 2020

May 15, 2020

BUY
$243.44 - $359.98 $119,285 - $176,390
490 Added 720.59%
558 $153,000
Q4 2019

Feb 03, 2020

SELL
$281.18 - $322.05 $8,716 - $9,983
-31 Reduced 31.31%
68 $17,000
Q2 2019

Jul 24, 2019

SELL
$279.29 - $336.89 $18,991 - $22,908
-68 Reduced 40.72%
99 $33,000
Q1 2019

Apr 29, 2019

BUY
$246.18 - $297.25 $36,680 - $44,290
149 Added 827.78%
167 $47,000
Q4 2017

Jan 31, 2018

SELL
$217.88 - $244.43 $1,960 - $2,199
-9 Reduced 33.33%
18 $3,000
Q2 2017

Aug 15, 2017

BUY
N/A
27
27 $3,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.